Found 33 matching trials
Investigating the Clinical Consequences of Flutemetamol-PET-scanning
PHASE3The study examines subjects where there might be an indication for Amyloid-...
Location
University of Zurich, Institute for Regenerative Medicine, Center for Prevention and Dementia Therapy
Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy
PHASE118F-Flutemetamol (Vizamyl) is a radioactive diagnostic agent indicated and ...
Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
NAThis research aim to explore relationships between the presence of amyloid ...
Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects
N/AThe primary objective of this study is to demonstrate that individuals with...
Location
University of Utah
Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
N/AStudy to understand factors related with the preclinical stages of Alzheime...
Location
BarcelonaBeta Brain Research Center
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
PHASE3Amyloid is an abnormal chemical found in the brain of patients with Alzheim...
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
PHASE3This study will determine the level of association between the quantitative...
18F-Flutemetamol and Plaque Vulnerability
PHASE2Rationale: Amyloid beta (Ab) is mainly known for its role in Alzheimer's di...
Location
Maastricht University Medical Centre (MUMC+)
Implications for Management of PET Amyloid Classification Technology
N/AThe main purpose of this study is to explore the impact of an amyloid posit...
Location
Center for Alzheimer's Care, Imaging & Research
Applying PET/MR for Dementia Applications
NADementia is a common disorder affecting about 50 million people worldwide w...
Location
Multiple Locations